Global Adult Hemoglobinopathy Testing Market to Reach $513.7 Million by 2030
The global market for Adult Hemoglobinopathy Testing estimated at US$368.6 Million in the year 2022, is projected to reach a revised size of US$513.7 Million by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030. HPLC Test, one of the segments analyzed in the report, is projected to record 3.9% CAGR and reach US$314.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mass Spectrometry segment is readjusted to a revised 4.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $98.2 Million, While China is Forecast to Grow at 6.6% CAGR
The Adult Hemoglobinopathy Testing market in the U.S. is estimated at US$98.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$110.4 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.Select Competitors (Total 44 Featured) -
- BioMedomics Inc.
- Bio-Rad Laboratories, Inc.
- Chromsystems Instruments & Chemicals GmbH
- PerkinElmer, Inc.
- Streck, Inc.
- Thermo Fisher Scientific, Inc.
- Trinity Biotech PLC
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Adult Hemoglobinopathy Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for HPLC Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for HPLC Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for HPLC Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Hb Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Hb Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for Hb Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 17: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 18: World 16-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Academic & Medical Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 20: World Historic Review for Academic & Medical Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 21: World 16-Year Perspective for Academic & Medical Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- Table 22: World Adult Hemoglobinopathy Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 23: USA Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 24: USA Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 25: USA 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 27: USA Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 28: USA 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
CANADA
- Table 29: Canada Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 30: Canada Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 31: Canada 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 33: Canada Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 34: Canada 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
JAPAN
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 35: Japan Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 36: Japan Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 37: Japan 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 39: Japan Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 40: Japan 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
CHINA
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 41: China Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 42: China Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 43: China 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 45: China Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 46: China 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
EUROPE
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 47: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 48: Europe Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 49: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 51: Europe Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 52: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 54: Europe Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 55: Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
FRANCE
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 56: France Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 57: France Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 58: France 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 59: France Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 60: France Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 61: France 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
GERMANY
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 62: Germany Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 63: Germany Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 64: Germany 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 65: Germany Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 66: Germany Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 67: Germany 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
ITALY
- Table 68: Italy Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 69: Italy Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 70: Italy 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 71: Italy Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 72: Italy Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 73: Italy 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 74: UK Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 75: UK Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 76: UK 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 77: UK Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 78: UK Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 79: UK 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
SPAIN
- Table 80: Spain Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 81: Spain Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 82: Spain 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 83: Spain Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 84: Spain Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 85: Spain 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
RUSSIA
- Table 86: Russia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 87: Russia Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 88: Russia 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 89: Russia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 90: Russia Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 91: Russia 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 92: Rest of Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 93: Rest of Europe Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 94: Rest of Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 95: Rest of Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 96: Rest of Europe Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 97: Rest of Europe 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 99: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 100: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
- Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 102: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 103: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2014, 2023 & 2030
- Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 105: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 106: Asia-Pacific 16-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2014, 2023 & 2030
AUSTRALIA
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
LATIN AMERICA
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
MIDDLE EAST
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
AFRICA
- Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BioMedomics Inc.
- Bio-Rad Laboratories, Inc.
- Chromsystems Instruments & Chemicals GmbH
- PerkinElmer, Inc.
- Streck, Inc.
- Thermo Fisher Scientific, Inc.
- Trinity Biotech PLC
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 174 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 368.6 Million |
Forecasted Market Value ( USD | $ 513.7 Million |
Compound Annual Growth Rate | 4.2% |
Regions Covered | Global |